Povidone Iodine and Cesarean Section Wound Infections
Primary Purpose
Wound Infections
Status
Completed
Phase
Phase 3
Locations
Egypt
Study Type
Interventional
Intervention
Povidone Iodine 10% vand cesarean section wound infections
Povidone Iodine 7.5% vand cesarean section wound infections
Sponsored by
About this trial
This is an interventional prevention trial for Wound Infections focused on measuring Betadine, Povidine Iodine, Hand scrubbing, Cesarean section wound infections, post cesarean section
Eligibility Criteria
Inclusion Criteria:
- elective caesarian section (CS)
Exclusion Criteria:
- diabetes,
- immuno-compromised patients
Sites / Locations
- Women Health Hospital - Assiut university
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Povidone Iodine 10%
Povidone Iodine 7.5% hand scrub
Arm Description
Using Povidone Iodine 10% hand scrub before caesarian section
Using Povidone Iodine 7.5% hand scrub before caesarian section
Outcomes
Primary Outcome Measures
The difference of incidence of surgical site infection between both groups
Determine the difference in incidence of surgical site infection between Povidone Iodine 10% versus 7.5% hand scrub
Secondary Outcome Measures
The difference in the side effects between both groups e.g. dermatitis
Determine the difference in incidence of side effects between Povidone Iodine 10% versus 7.5% hand scrub
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01700803
Brief Title
Povidone Iodine and Cesarean Section Wound Infections
Official Title
Povidone Iodine 10% Versus 7.5% Hand Scrub and Cesarean Section Wound Infections: A Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2012
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
April 2012 (Actual)
Study Completion Date
May 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this randomized clinical trial is to compare the efficiency of hand scrubbing by Povidone-Iodine solution 10% over 7.5% concentration in decreasing post-cesarean section wound infections & compare side effects of both agents.
Detailed Description
For centuries, hand washing with soap and water has been considered the main approach for personal hygiene. In the community, hand hygiene has been known to prevent infectious diseases and to decrease the burden of disease. Currently, hand hygiene is considered the most important measure for preventing the spread of pathogens in health-care settings.
There are multiple agents used for surgical hand scrubbing as alcohol, chlorhexidine, iodine/iodophors, para-chloro-meta-xylenol & triclosan. Ideally, the optimum antiseptic used for scrub should have broad spectrum of activity, persistent effect & fast acting. Unfortunately most studies evaluating surgical scrub antiseptics have focused on measuring hand bacterial colony counts. No randomized clinical trials have evaluated the impact of surgical scrub choice on surgical site infection risk & proven its efficiency.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound Infections
Keywords
Betadine, Povidine Iodine, Hand scrubbing, Cesarean section wound infections, post cesarean section
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
Participant
Allocation
Randomized
Enrollment
3231 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Povidone Iodine 10%
Arm Type
Experimental
Arm Description
Using Povidone Iodine 10% hand scrub before caesarian section
Arm Title
Povidone Iodine 7.5% hand scrub
Arm Type
Experimental
Arm Description
Using Povidone Iodine 7.5% hand scrub before caesarian section
Intervention Type
Drug
Intervention Name(s)
Povidone Iodine 10% vand cesarean section wound infections
Intervention Type
Drug
Intervention Name(s)
Povidone Iodine 7.5% vand cesarean section wound infections
Primary Outcome Measure Information:
Title
The difference of incidence of surgical site infection between both groups
Description
Determine the difference in incidence of surgical site infection between Povidone Iodine 10% versus 7.5% hand scrub
Time Frame
4 month
Secondary Outcome Measure Information:
Title
The difference in the side effects between both groups e.g. dermatitis
Description
Determine the difference in incidence of side effects between Povidone Iodine 10% versus 7.5% hand scrub
Time Frame
4 month
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
elective caesarian section (CS)
Exclusion Criteria:
diabetes,
immuno-compromised patients
Facility Information:
Facility Name
Women Health Hospital - Assiut university
City
Assiut
ZIP/Postal Code
71111
Country
Egypt
12. IPD Sharing Statement
Learn more about this trial
Povidone Iodine and Cesarean Section Wound Infections
We'll reach out to this number within 24 hrs